Cape Investment Advisory, Inc.

Position in ABBV — AbbVie Inc.

CIK 1944437 MCDONOUGH, GA

Position in ABBV

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$356,573

+$44,476 QoQ

Shares Held

1,417

-1.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.25%

of 13F equity value

Holder Rank

#3,462

of 4,153 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Cape Investment Advisory, Inc. holds $3,326,940 across 15 Drug Manufacturers - General names. ABBV ranks #4 (10.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	2,880	$731,432
2	LLY	ELI LILLY & Co	464	$556,535
3	GSK	GSK plc	9,228	$483,731
4	ABBV	AbbVie Inc. This page	1,417	$356,573
5	MRK	Merck & Co., Inc.	2,665	$342,452
6	PFE	Pfizer Inc	12,694	$305,671
7	AMGN	Amgen Inc	631	$228,497
8	NVS	Novartis AG	747	$117,069

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$356,573	1,417	-1.3%	Shares	Sole	2026-07-23
2026-03-31	$312,097	1,435	+4.4%	Shares	Sole	2026-05-15
2025-12-31	$313,945	1,374	+440.9%	Shares	Sole	2026-02-17
2025-09-30	$58,811	254	-82.5%	Shares	Sole	2025-12-29
2025-06-30	$268,963	1,449	-9.0%	Shares	Sole	2025-08-19
2025-03-31	$333,765	1,593	-1.2%	Shares	Sole	2025-05-16
2024-12-31	$286,452	1,612	+16.1%	Shares	Sole	2025-02-05
2024-09-30	$274,102	1,388	-2.7%	Shares	Sole	2024-11-14
2024-06-30	$244,587	1,426	-7.0%	Shares	Sole	2024-08-15
2024-03-31	$279,341	1,534	-4.8%	Shares	Defined	2024-06-21
2023-12-31	$249,811	1,612	+5.2%	Shares	Sole	2024-02-12
2023-09-30	$228,359	1,532	-5.4%	Shares	Defined	2023-11-07
2023-06-30	$218,262	1,620	+3.1%	Shares	Sole	2023-10-12
2023-03-31	$250,370	1,571	—	Shares	Sole	2023-10-12
No filing history on record for this holder in this stock.